Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Bender

Showing results (211-220 of 254) with videos related to

Pageof 26
Sort By:
Blood|June 1, 1990
Further studies on growth factor production by the TC-1 stromal cell line: pre-B stimulating activityT A Woodward, I K McNiece, P L Witte, et al.
ACS Applied Materials & Interfaces|November 27, 2013
Green-sensitive organic photodetectors with high sensitivity and spectral selectivity using subphthalocyanine derivativesKwang-Hee Lee, Dong-Seok Leem, Jeffrey S Castrucci, et al.
Gynecologic Oncology|December 28, 2018
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyUrsula A Matulonis, Michael W Sill, Vicky Makker, et al.
Acta Neuropathologica|March 30, 2016
Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signalingPreeti Yadav, Bhuvaneish T Selvaraj, Florian L P Bender, et al.
Oncotarget|December 2, 2015
Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breastZoran Gatalica, Semir Vranic, Anatole Ghazalpour, et al.
Nanoscale Advances|September 22, 2022
Identifying the presence of magnetite in an ensemble of iron-oxide nanoparticles: a comparative neutron diffraction study between bulk and nanoscaleD González-Alonso, J I Espeso, H Gavilán, et al.
Elife|December 6, 2017
A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in miceFei Tang, Peng Zhang, Peiying Ye, et al.
Cancer|December 21, 2023
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancerBobbie J Rimel, Danielle Enserro, David P Bender, et al.
International Journal of Molecular Sciences|March 15, 2019
Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian CancerMegan E McDonald, Erin A Salinas, Eric J Devor, et al.
Scientific Reports|March 17, 2021
Creation and validation of models to predict response to primary treatment in serous ovarian cancerJesus Gonzalez Bosquet, Eric J Devor, Andreea M Newtson, et al.
Pageof 26

Showing results (211-220 of 254) with videos related to

Sort By:
Pageof 26
Blood|June 1, 1990
Further studies on growth factor production by the TC-1 stromal cell line: pre-B stimulating activityT A Woodward, I K McNiece, P L Witte, et al.
ACS Applied Materials & Interfaces|November 27, 2013
Green-sensitive organic photodetectors with high sensitivity and spectral selectivity using subphthalocyanine derivativesKwang-Hee Lee, Dong-Seok Leem, Jeffrey S Castrucci, et al.
Gynecologic Oncology|December 28, 2018
A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group studyUrsula A Matulonis, Michael W Sill, Vicky Makker, et al.
Acta Neuropathologica|March 30, 2016
Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signalingPreeti Yadav, Bhuvaneish T Selvaraj, Florian L P Bender, et al.
Oncotarget|December 2, 2015
Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breastZoran Gatalica, Semir Vranic, Anatole Ghazalpour, et al.
Nanoscale Advances|September 22, 2022
Identifying the presence of magnetite in an ensemble of iron-oxide nanoparticles: a comparative neutron diffraction study between bulk and nanoscaleD González-Alonso, J I Espeso, H Gavilán, et al.
Elife|December 6, 2017
A population of innate myelolymphoblastoid effector cell expanded by inactivation of mTOR complex 1 in miceFei Tang, Peng Zhang, Peiying Ye, et al.
Cancer|December 21, 2023
NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancerBobbie J Rimel, Danielle Enserro, David P Bender, et al.
International Journal of Molecular Sciences|March 15, 2019
Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian CancerMegan E McDonald, Erin A Salinas, Eric J Devor, et al.
Scientific Reports|March 17, 2021
Creation and validation of models to predict response to primary treatment in serous ovarian cancerJesus Gonzalez Bosquet, Eric J Devor, Andreea M Newtson, et al.
Pageof 26